The Diabetes Drug Actos May Cause An Increased Risk of Bladder Cancer That Can Metastasize into Lung Cancer, Lymphatic Cancer, Liver Cancer, Bone Cancer, Prostate Cancer, Rectum Cancer, or Vaginal Cancer by Texas Actos Bladder Cancer Lawyer, Texas Diabetes Drug Cancer Lawyer, Diabetes Bladder Cancer Lawyer, and Texas Actos Cancer Death Lawyer

The Diabetes Drug Actos May Cause An Increased Risk of Bladder Cancer That Can Metastasize into Lung Cancer, Lymphatic Cancer, Liver Cancer, Bone Cancer, Prostate Cancer, Rectum Cancer, or Vaginal Cancer by Texas Actos Bladder Cancer Lawyer, Diabetes Drug Cancer Lawyer, Diabetes Bladder Cancer Lawyer, and Texas Actos Cancer Death Lawyer

Actos is a diabetes drug that has been prescribed to more than 10 million Americans since its approval for the treatment of type 2 diabetes.  It is an extremely profitable drug in that it has had multi-billion dollar annual global sales and has created large profits for its manufacturer.  Actos is manufactured by Takeda Pharmaceutical Co.  However, Actos has been linked to an increased risk of bladder cancer and has been pulled off the market in some European countries.  Actos is now under review by the FDA to determine if it will be pulled from the market or additional black box warnings will be added to the drug. 

Actos May Cause An Increased Risk of Bladder Cancer

Bladder Cancer is a form of cancer that begins in the lining of the bladder as a superficial tumor.  Bladder cancer can spread and metastasize into the lungs, liver, or bones resulting in serious health issues and even death. If left untreated bladder cancer can metastasize into lung cancer, lymphatic cancer, liver cancer, bone cancer, prostate cancer, rectum cancer, uterine cancer, and vaginal cancer. The most common symptom of bladder cancer is blood in the urine.  If you or a loved one have been taking Actos and have experienced blood in your urine, please contact your doctor immediately.  If you suffer from bladder cancer, lung cancer, lymphatic cancer, liver cancer, bone cancer, prostate cancer, rectum cancer, uterine cancer, or vaginal cancer and were taking Actos, please report the adverse facts.  If you have lost a person that you love from a bladder cancer, lung cancer, lymphatic cancer, liver cancer, bone cancer, prostate cancer, rectum cancer, uterine cancer, or vaginal cancer and your loved one was taking Actos, please report the adverse facts.

  Bladder Cancer Can Be Treated If Caught Early: People That Have Taken Actos or Are Taking Actos Should Be Aware of the Warning Signs of Bladder Cancer and Communicate with Their Doctor To Make Sure that They Are Both Aware of Any Symptoms by Texas Actos Bladder Cancer Lawyer, Texas Diabetes Drug Cancer Lawyer, Diabetes Bladder Cancer Lawyer, and Texas Actos Cancer Death Lawyer

Most bladder cancers begin in the transitional cells as transitional cell carcinoma, but can spread into nearby organs.  When bladder cancer spreads beyond the bladder, the malignant cells are frequently found in nearby lymph nodes and may have spread to other lymph nodes or other places including the lungs, liver, or bones.  The most common warning sign is blood in the urine. If there is enough blood to color the urine it may range from slightly rusty to deep red. Other symptoms may be pain during urination and frequent urination or feeling the need to urinate without results. 

Bladder cancer can be diagnosed into several different stages.  Stage 0 Bladder Cancer patients have noninvasive tumors that are only in the bladder lining; Stage I Bladder Cancer Patients have tumor(s) through the bladder lining, but the tumor(s) do not reach the muscle layer of the bladder; Stage II Cancer Patients have tumor(s) that go into the muscle layer of the bladder; Stage III Cancer Patients have tumor(s) that go past the muscle layer into tissue surrounding the bladder; and Stage IV Bladder Cancer Patients have tumor(s) that have spread to neighboring lymph nodes or to distant sites (metastatic disease) including the lungs, liver, bones, prostate, stomach, rectum, ureters, uterus,  and vagina.

Primary malignant bladder cancer can be classified by health care providers in several different categories depending on where it is found including the dome of urinary bladder; lateral wall of urinary bladder; anterior wall of urinary bladder; posterior wall of urinary bladder; bladder neck; ureteric orifice; urachus; and malignant neoplasm of contiguous or overlapping sites of bladder whose point of origin cannot be determined.

Carcinoma in situ is cancer that remains confined to the bladder lining. Bladder cancer may grow into or through the bladder wall and eventually into lymph nodes, lungs, liver, bones, or other nearby areas.